Inhaled NO is used for the treatment of pulmonary hypertension in new born, pre-term neonates with hypoxic respiratory failure [11] and phosphodiesterase inhibitors (PDE) for example, sildenafil therapy to improve hemodynamics in the children with pulmonary hypertension [12]. The gene discussed is ALDH7A1; the disease is pulmonary arterial hypertension.